Design to come?

WP_Post Object
(
    [ID] => 1898
    [post_author] => 3
    [post_date] => 2023-10-09 13:44:53
    [post_date_gmt] => 2023-10-09 18:44:53
    [post_content] => 
    [post_title] => Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402 for the Treatment of Arrhythmogenic Cardiomyopathy
    [post_excerpt] => 
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => rejuvenate-bio-announces-preclinical-data-for-gene-therapy-candidate-rjb-0402-for-the-treatment-of-arrhythmogenic-cardiomyopathy
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2023-10-12 13:45:47
    [post_modified_gmt] => 2023-10-12 18:45:47
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://vcapital.com/?post_type=news&p=1898
    [menu_order] => 0
    [post_type] => news
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
)